141 related articles for article (PubMed ID: 31549121)
1. Two is better than one: difunctional high-affinity PSMA probes based on a [CpM(CO)
Frei A; Fischer E; Childs BC; Holland JP; Alberto R
Dalton Trans; 2019 Oct; 48(39):14600-14605. PubMed ID: 31549121
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.
Hillier SM; Maresca KP; Lu G; Merkin RD; Marquis JC; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
J Nucl Med; 2013 Aug; 54(8):1369-76. PubMed ID: 23733925
[TBL] [Abstract][Full Text] [Related]
3. Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA).
Ray Banerjee S; Pullambhatla M; Foss CA; Falk A; Byun Y; Nimmagadda S; Mease RC; Pomper MG
J Med Chem; 2013 Aug; 56(15):6108-21. PubMed ID: 23799782
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR of ⁹⁹mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates.
Lu G; Maresca KP; Hillier SM; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioorg Med Chem Lett; 2013 Mar; 23(5):1557-63. PubMed ID: 23333070
[TBL] [Abstract][Full Text] [Related]
5. Preparation and Biological Evaluation of [
Xiao D; Duan X; Gan Q; Zhang X; Zhang J
Molecules; 2020 Nov; 25(23):. PubMed ID: 33256058
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).
Banerjee SR; Foss CA; Castanares M; Mease RC; Byun Y; Fox JJ; Hilton J; Lupold SE; Kozikowski AP; Pomper MG
J Med Chem; 2008 Aug; 51(15):4504-17. PubMed ID: 18637669
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Radiolabeling of Glu-Urea-Lys with
Hatamabadi D; Joukar S; Shakeri P; Balalaie S; Yazdani A; Khoramjouy M; Mazidi SM; Kobarfard F; Mosayebnia M; Bozorgchami N; Ahmadi M; Ayyoubzadeh SM; Shahhosseini S
Cancer Biother Radiopharm; 2023 Sep; 38(7):486-496. PubMed ID: 37578479
[No Abstract] [Full Text] [Related]
8. Mixed tridentate π -donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals.
Boschi A; Uccelli L; Pasquali M; Pasqualini R; Guerrini R; Duatti A
Curr Radiopharm; 2013 Sep; 6(3):137-45. PubMed ID: 24106999
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.
Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ
J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024
[TBL] [Abstract][Full Text] [Related]
10. Isothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate Cancer.
Kasten BB; Ma X; Cheng K; Bu L; Slocumb WS; Hayes TR; Trabue S; Cheng Z; Benny PD
Bioconjug Chem; 2016 Jan; 27(1):130-42. PubMed ID: 26603218
[TBL] [Abstract][Full Text] [Related]
11. Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer.
Kratochwil C; Afshar-Oromieh A; Kopka K; Haberkorn U; Giesel FL
Semin Nucl Med; 2016 Sep; 46(5):405-18. PubMed ID: 27553466
[TBL] [Abstract][Full Text] [Related]
12. (R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors.
Gourni E; Canovas C; Goncalves V; Denat F; Meyer PT; Maecke HR
PLoS One; 2015; 10(12):e0145755. PubMed ID: 26700033
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of Re/
Radford LL; Papagiannopoulou D; Gallazzi F; Berendzen A; Watkinson L; Carmack T; Lewis MR; Jurisson SS; Hennkens HM
Bioorg Med Chem; 2019 Feb; 27(3):492-501. PubMed ID: 30594453
[TBL] [Abstract][Full Text] [Related]
14. NOTA and NODAGA [
Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer.
Vallabhajosula S; Nikolopoulou A; Babich JW; Osborne JR; Tagawa ST; Lipai I; Solnes L; Maresca KP; Armor T; Joyal JL; Crummet R; Stubbs JB; Goldsmith SJ
J Nucl Med; 2014 Nov; 55(11):1791-8. PubMed ID: 25342385
[TBL] [Abstract][Full Text] [Related]
16. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
[TBL] [Abstract][Full Text] [Related]
17. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.
Bartholomä M; Valliant J; Maresca KP; Babich J; Zubieta J
Chem Commun (Camb); 2009 Feb; (5):493-512. PubMed ID: 19283279
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.
Evazalipour M; D'Huyvetter M; Tehrani BS; Abolhassani M; Omidfar K; Abdoli S; Arezumand R; Morovvati H; Lahoutte T; Muyldermans S; Devoogdt N
Contrast Media Mol Imaging; 2014; 9(3):211-20. PubMed ID: 24700748
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer.
Eder M; Schäfer M; Bauder-Wüst U; Haberkorn U; Eisenhut M; Kopka K
Prostate; 2014 May; 74(6):659-68. PubMed ID: 24464532
[TBL] [Abstract][Full Text] [Related]
20. Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled Bisphosphonates.
Makris G; Tseligka ED; Pirmettis I; Papadopoulos MS; Vizirianakis IS; Papagiannopoulou D
Mol Pharm; 2016 Jul; 13(7):2301-17. PubMed ID: 27170456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
